茅以诚
药理学与生物化学, 讲师

姓      名

 茅以诚

性      别

 女

职      称

 讲师

学      历

 博士

电      话

 021-51980041

传      真

 021-51980041

电子邮件

 maoyc@fudan.edu.cn

个人主页

 

通讯地址

 上海浦东新区张衡路826号科研楼425室 邮编:201203

个人简历        2012年毕业于美国俄亥俄州立大学(The Ohio State University)药学院,获药剂学博士学位。2013年加入复旦大学药学院药理学与生物化学教研室,曾参与多项美国国家科学基金会(NSF)及美国国立卫生研究院(NIH)项目。目前主持国家自然科学基金(青年基金)1项,于2014年入选上海市科委浦江人才计划(A类),并获得2014年度“晨光学者”资助(A类)。已以第一作者发表SCI论文5篇,以共同作者发表SCI论文10余篇。

 

研究方向

 主要研究方向为药物新剂型优化及其药理研究。

 

代表性论著
1.  Y Mao*,J Wang, Y Zhao, Y Wu, KJ Kwak, C-S Chen, JC Byrd, RJ Lee, MA Phelps, LJ Lee & N Muthusamy. A Novel Liposomal Formulation of FTY720 (Fingolimod) for Promising Enhanced Targeted Delivery.Nanomedicine: NBM.,2014, 10, 393. 
2.  Y Mao*, G Triantafillou*, E Hertlein, W Towns, M Stefanovski, X Mo, D Jarjoura, M Phelps, G Marcucci, L J Lee, D Goldenberge, RJ. Lee, JC Byrd & N Muthusamy.Milatuzumab-Conjugated Liposomes as Targeted Dexamethasone Carriers for Therapeutic Delivery in CD74+ B-Cell Malignancies.Clin. Cancer Res., 2013, 19: 347.
3. B Yu*, Y Mao*, Y Yuan, C Yue, X Wang, X Mo, D Jarjoura, ME Parlaitis, RJ Lee, JC Byrd, LJ Lee & N Muthusamy. Targeted Drug Delivery and Cross-linking Induced Apoptosis with Anti-CD37 Based Dual-Ligand Immunoliposomes in B Chronic Lymphocytic Leukemia Cells. Biomaterials,2013, 34: 6185.
4. R Mani*, Y Mao*, FW Frissora, CL Chiang, J Wang, Y Zhao, Y Wu, B Yu, R Yan, X Mo, L Yu, J Flynn, J Jones, L Andritsos, S Baskar, C Rader, MA Phelps, CS Chen, RJ Lee, JC Byrd, LJ Lee & N Muthusamy. Tumor antigen ROR1 targeted drug delivery mediated selective leukemic but not normal B-cell cytotoxicity in chronic lymphocytic leukemia. Leukemia,2015,29(2): 346.
5. Y Mao*, J Wang*, Y Zhao, R Yan, H Li, CS Chen, RJ Lee, JC Byrd, LJ Lee, N Muthusamy& MA Phelps. Quantification of OSU-2S, a novel derivative of FTY720, in mouse plasma by liquid chromatography-tandem mass spectrometry.J Pharm Biomed Anal, 2014, 98:160 



打印 返回